Title : Management of gastrointestinal stromal tumors in the imatinib era: selected case studies.

Pub. Date : 2006 Jan

PMID : 16401709






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 The introduction of imatinib, an orally administered inhibitor of the KIT receptor tyrosine kinase, is prompting revision of the management algorithms that have traditionally guided the treatment of gastrointestinal stromal tumor (GIST). Imatinib Mesylate ret proto-oncogene Homo sapiens